None
Quote | SCYNEXIS Inc. (NASDAQ:SCYX)
Last: | $1.9562 |
---|---|
Change Percent: | 0.32% |
Open: | $1.96 |
Close: | $1.95 |
High: | $1.96 |
Low: | $1.9201 |
Volume: | 26,866 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | SCYNEXIS Inc. (NASDAQ:SCYX)
2024-05-31 11:50:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The ability to recognize possibilities while investing can frequently be the difference between stagnation and growth in an unstable and changing economic environment. Here are three exciting s...
2024-05-23 06:42:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Finding good prospects is like hunting gold in the fast-paced world of investing. Three stocks stand out in this hunt, all under $10, with significant growth potential. These companies operate ...
Message Board Posts | SCYNEXIS Inc. (NASDAQ:SCYX)
Subject | By | Source | When |
---|---|---|---|
Gap fills in the 1.8's, golden cross around | BooDog | investorshub | 04/24/2023 3:12:38 PM |
Buy orders getting triggered. Just watch | BooDog | investorshub | 04/12/2023 4:40:04 PM |
Placed a buy order at 3.39 and took | duderaja | investorshub | 04/04/2023 2:08:55 PM |
Check this out: | duderaja | investorshub | 04/03/2023 7:28:52 PM |
$SCYX: Hey, THANKS, Capt. S-L!!! (& best of | Invest-in-America | investorshub | 04/03/2023 6:41:25 PM |
News, Short Squeeze, Breakout and More Instantly...
SCY-247’s IND-enabling activities continue to progress, with initiation of Phase I anticipated in the second half of 2024 Clinical study reports for the FURI, CARES and NATURE trials in refractory invasive fungal infections remain on track for delivery to GSK in mid 2024, which would...